Vivoryon Therapeutics NV
LSE:0R3M
Vivoryon Therapeutics NV
LSE:0R3M
Price:
1.28
EUR
-1.54%
Market Closed
Market Cap:
€37.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Vivoryon Therapeutics NV
LSE:0R3M
|
DE |
|
Health Catalyst Inc
NASDAQ:HCAT
|
US |
|
B
|
Barclays PLC
BMV:BCSN
|
UK |
|
S
|
Suzuki Motor Corp
SWB:SUK
|
JP |
|
T
|
Telefonica SA
SWB:TNE5
|
ES |
|
S
|
Steel Dynamics Inc
SWB:SD5
|
US |
|
U
|
United Utilities Group PLC
XBER:UUEC
|
UK |
|
Asahi Intecc Co Ltd
OTC:AHICF
|
JP |
|
C
|
Compagnie de Saint Gobain SA
XETRA:GOB
|
FR |
|
Pyxis Tankers Inc
NASDAQ:PXS
|
GR |
|
B
|
British American Tobacco PLC
XMUN:BMT
|
UK |
|
CBAK Energy Technology Inc
LSE:0A98
|
CN |
|
B
|
Berentzen Gruppe AG
F:BEZ
|
DE |
|
R
|
Radian Group Inc
XMUN:RAG
|
US |
|
N
|
Next PLC
SWB:NXG
|
UK |
Wall St Price Targets
0R3M Price Targets Summary
Vivoryon Therapeutics NV
Vivoryon Therapeutics NV
Wall Street analysts forecast 0R3M stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 0R3M is 5.97 EUR with a low forecast of 5.07 EUR and a high forecast of 7.91 EUR.
Lowest Forecast
Price Target
5.07
EUR
296% Upside
Average Forecast
Price Target
5.97
EUR
367% Upside
Highest Forecast
Price Target
7.91
EUR
518% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0R3M's stock price target?
Price Target
5.97
EUR
5.97
EUR
According to Wall Street analysts, the average 1-year price target for 0R3M is 5.97 EUR with a low forecast of 5.07 EUR and a high forecast of 7.91 EUR.
